Frier Levitt has been featured in a Crain’s New York Business article titled, “CVS Pharmacy Benefit Manager Must Pay $22M in Oncology Treatment Fees.” The article centers on the recent $22 million arbitration award against Caremark on behalf of New York Cancer & Blood Specialists, who Frier Levitt represented. The article summarizes the case, highlighting that this is yet another hit against Pharmacy Benefit Managers (PBMs) for their unfair and abusive pricing practices. The piece also explores District Judge Naomi Buchwald’s decision, providing key insights into the ruling. This case represents a significant milestone in the ongoing fight against PBMs, and Frier Levitt is proud to have achieved this victory for our client and to further the broader mission of promoting transparency and fairness in the healthcare and life sciences sectors.
Read the article here: https://www.crainsnewyork.com/health-pulse/pharmacy-benefit-manager-must-pay-oncology-drug-costs
